Literature DB >> 25267957

Standard versus limited colon resection for high risk T1 colon cancer. A matched case-control study.

Marco La Torre1, Giuseppe Nigri2, Federica Mazzuca3, Mario Ferri2, Andrea Botticelli3, Laura Lorenzon2, Emanuela Pilozzi2, Vincenzo Ziparo2.   

Abstract

BACKGROUND AND AIMS: The National Comprehensive Cancer Network (NCCN) recommends a colectomy in presence of high risk T1 colon polyps considering the risk of incomplete lymph node dissection or presence of residual disease. We evaluated the outcomes of segmental versus standard colon resection for high risk T1 colon cancers, in order to demonstrate if segmental colectomy (SegCR) allows same short-term and oncological results compared to standard radical colectomy (StaCR). METHODS. A matched case-control study on patients who had undergone segmental versus standard colon resection was performed. One-hundred and two patients with high risk T1 colon cancer after endoscopic polypectomy, divided in 2 homogeneous groups of 51 cases, were analyzed and intra-operative, post-operative and oncological data were compared. RESULTS. Segmental colectomy allowed less operative time and intra-operative blood loss compared to StaCR (p < 0.001). Hospital stay after SegCR was shorter compared to StaCR (p < 0.001). No differences were found in terms of overall morbidity and mortality rates. Five-year actuarial overall, disease-free and disease-specific survival after StaCR were similar to SegCR (87%, 96% and 95% vs. 88%, 97% and 94%, respectively, p = 0.51, p=0.33, p=0.78). CONCLUSIONS. According to our findings, SegCR can be a valid alternative to StaCR for high risk T1 colon polyps. Segmental colectomy allows better peri-operative outcomes compared to StaCR ensuring the same oncological long-term outcomes.

Entities:  

Mesh:

Year:  2014        PMID: 25267957     DOI: 10.15403/jgld.2014.1121.233.mlt

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  3 in total

1.  T1 colon cancer in the era of screening: risk factors and treatment.

Authors:  F Bianco; S De Franciscis; A Belli; A Falato; R Fusco; D F Altomare; A Amato; C R Asteria; A Avallone; G A Binda; L Boccia; P Buzzo; M Carvello; C Coco; P Delrio; P De Nardi; M Di Lena; A Failla; F La Torre; M La Torre; M Lemma; P Luffarelli; G Manca; I Maretto; F Marino; A Muratore; A Pascariello; S Pucciarelli; D Rega; V Ripetti; G Rizzo; A Serventi; A Spinelli; F Tatangelo; E D L Urso; G M Romano
Journal:  Tech Coloproctol       Date:  2017-02-13       Impact factor: 3.781

2.  The prognostic value of lymph node yield in the earliest stage of colorectal cancer: a multicenter cohort study.

Authors:  Yara Backes; Sjoerd G Elias; Bibie S Bhoelan; John N Groen; Jeroen van Bergeijk; Tom C J Seerden; Hendrikus J M Pullens; Bernhard W M Spanier; Joost M J Geesing; Koen Kessels; Marjon Kerkhof; Peter D Siersema; Wouter H de Vos Tot Nederveen Cappel; Niels van Lelyveld; Frank H J Wolfhagen; Frank Ter Borg; G Johan A Offerhaus; Miangela M Lacle; Leon M G Moons
Journal:  BMC Med       Date:  2017-07-14       Impact factor: 8.775

3.  Technical challenges and potential solutions for rectal and sigmoid tumours following previous radiation for prostate malignancy: A case series.

Authors:  Enda Hannan; Jessica Ryan; Desmond Toomey
Journal:  Int J Surg Case Rep       Date:  2020-07-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.